Question · Q4 2025
Will Power inquired about Axon's confidence and visibility in sustaining growth rates through 2027 and 2028, seeking insights on contributions from existing versus new products, with any particular standouts. He also asked for an update on AI bookings strength, pipeline, and product roadmap, specifically if AI bookings could double this year.
Answer
CEO Rick Smith noted that Axon is still growing into new offerings like the AI Era Plan and new OSP versions, with Dedrone highlighted as a potential exciting contributor, especially in federal and international markets. COO and CFO Brittany Bagley affirmed that the 2028 targets do not require forecasting major changes, expecting product lines and markets to continue their current growth trajectory. Josh Isner described AI adoption as being in the 'very early innings,' with significant pipeline and opportunities to deploy more AI products annually.
Ask follow-up questions
Fintool can predict
AXON's earnings beat/miss a week before the call
